XuYan
Academic / Other · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Safety and Efficacy of Anti-GPRC5D CAR-T Cells Therapy in the Treatment of r/r MM Multiple Myeloma in Relapse, Multiple Myeloma, Refractory | Phase 1 / Phase 2 | 2023-04-10 |